Natus swings to number one in sleep apnoea market with Embla buy
This article was originally published in Clinica
Executive Summary
Natus Medical has acquired Embla Systems, the biggest pure-play sleep diagnostics company. The move significantly boosts Natus's existing presence in sleep diagnostics and propels it to the number one position in the global market for these products, according to the San Carlos, California firm.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.